Quince Therapeutics (QNCX) Exchange Rate Effect (2021 - 2026)
Quince Therapeutics (QNCX) posted Exchange Rate Effect of -$229000.0 for Q2 2026, up 84.34% on a QoQ basis from -$1.5 million in Q1 2026, and down 1305.26% year-over-year from $19000.0 in Q2 2025.
Analysis
Quince Therapeutics (QNCX) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Quince Therapeutics has reported Exchange Rate Effect for 6 years, with the latest figure at -$229000.0 in Q2 2026.
- On a quarterly basis, Exchange Rate Effect fell 1305.26% year-over-year to -$229000.0 in Q2 2026; TTM through Jun 2026 was -$2.0 million, a 661.52% decrease from a year earlier, with the FY2025 full-year figure at -$114000.0, down 149.35% from the prior year.
- Exchange Rate Effect was -$229000.0 for Q2 2026 at Quince Therapeutics, up from -$1.5 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $409000.0 in Q3 2022, with the low at -$1.5 million in Q1 2026.
- Average Exchange Rate Effect over 5 years is -$72777.8, with a median of -$42000.0 recorded in 2022.
- The sharpest annual moves came in 2022 and 2026: Exchange Rate Effect soared 1310.34% in 2022, then tumbled 1305.26% in 2026.
- Over 5 years, Exchange Rate Effect stood at -$43000.0 in 2022, then sank by 479.07% to -$249000.0 in 2023, then jumped by 189.16% to $222000.0 in 2024, then plunged by 220.27% to -$267000.0 in 2025, then rose by 14.23% to -$229000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$229000.0 (Q2 2026), -$1.5 million (Q1 2026), and -$267000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 315,000.00 |
| 10 | Quince Therapeutics | 175.52 Mn | 175.52 Mn | - | -229,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -229,000.00 |
| Mar 31, 2026 | -1.46 Mn |
| Dec 31, 2025 | -267,000.00 |
| Sep 30, 2025 | -41,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Mar 31, 2025 | 175,000.00 |
| Dec 31, 2024 | 222,000.00 |
| Sep 30, 2024 | -60,000.00 |
| Jun 30, 2024 | -241,000.00 |
| Mar 31, 2024 | 310,000.00 |
| Dec 31, 2023 | -249,000.00 |
| Sep 30, 2023 | 155,000.00 |
| Jun 30, 2023 | 60,000.00 |
| Mar 31, 2023 | 114,000.00 |
| Dec 31, 2022 | -43,000.00 |
| Sep 30, 2022 | 409,000.00 |
| Jun 30, 2022 | -78,000.00 |
| Mar 31, 2022 | -104,000.00 |
| Dec 31, 2021 | 26,000.00 |
| Sep 30, 2021 | 29,000.00 |